Pediatric Endocrinology News

ATLANTA — Adolescent boys with overweight, obesity, hyperinsulinemia or insulin resistance have a lower testicular volume compared with those with normal weight, according to a presenter at ENDO 2022.

ATLANTA — Adolescents and young adults are eating less ultra-processed food since the start of the COVID-19 pandemic compared with before the pandemic, reversing a 30-year trend of increased ultra-processed food consumption.

NEW ORLEANS — Adults and children with type 1 diabetes who used an open-source automated insulin delivery system significantly increased time in target glucose range compared with baseline and with sensor-augmented pump therapy.

NEW ORLEANS — A new study identified a link between persistent racial residential segregation and worse diabetes health in Black adolescents with type 1 diabetes.

NEW ORLEANS — Adolescents’ risk for developing type 1 diabetes rose with increasing BMI, according to data presented at the American Diabetes Association Scientific Sessions and simultaneously published in Diabetologia.

NEW ORLEANS — Young people with type 2 diabetes taking the once-weekly GLP-1 receptor agonist dulaglutide had a decrease in HbA1c at 26 weeks without a significant change in BMI, according to findings from a phase 3 trial.

The FDA will reevaluate the safety of bisphenol A in food packaging, according to a press release from the Environmental Defense Fund.

Teens with severe obesity who lost weight maintained more of their weight loss with use of a GLP-1 receptor agonist plus lifestyle therapy compared with lifestyle therapy alone, according to study findings published in Obesity.

Among children diagnosed with ADHD, low doses of ADHD medications did not affect thyroid or growth hormone levels, according to study data.

Dasiglucagon lowers the amount of IV glucose required by more than 50% for infants with congenital hyperinsulinism, according to top-line results from a phase 3 clinical trial.